Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function

Abstract Background Robotic stereotactic ablative radiotherapy (SABR) is currently under investigation as a noninvasive treatment option for patients with renal cell carcinoma (RCC). For radiation therapy of RCC, tumor motion and the need for high ablative doses while preserving the remaining renal...

Full description

Bibliographic Details
Main Authors: C. Senger, A. Conti, A. Kluge, D. Pasemann, M. Kufeld, G. Acker, M. Lukas, A. Grün, G. Kalinauskaite, V. Budach, J. Waiser, C. Stromberger
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Urology
Subjects:
CyberKnife
Radiosurgery
SABR
Renal cell carcinoma
Kidney
Motion tracking
Online Access:http://link.springer.com/article/10.1186/s12894-019-0531-z

Internet

http://link.springer.com/article/10.1186/s12894-019-0531-z

Similar Items